MedPath

Effectiveness of the Treatment for Infant Iron Deficiency Anemia by Taking Lactoferrin and Ferralia

Not Applicable
Completed
Conditions
Iron Deficiency Anemia
Interventions
Other: Standard infant fomula
Other: Low level LF infant formula
Other: High level LF infant formula
Registration Number
NCT03534089
Lead Sponsor
Beingmate Baby & Child Food Co Ltd .
Brief Summary

A multi-center,randomized,double-blind,controlled clinical trial was used to investigate the effectiveness of the treatment of infant iron deficiency anemia by taking ferralia and different contents lactoferrin.

Detailed Description

5-9 months old infants with iron deficiency anemia were randomly divided into three groups. On the basis of giving the same dose of ferralia,three different levels lactoferrin infant formula were intervened 3 months respectively,and evaluate the clinical effect.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
135
Inclusion Criteria
  • Full term,healthy infants at 37-42 weeks of gestational age
  • 5-9 months old infants were diagnose as iron deficiency anemia
  • Accepting bottle feeding
Exclusion Criteria
  • Hb<60 g/L
  • Other microcytic, hypochromic anemia

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Standard infant fomulaStandard infant fomulaInfants with iron deficiency anemia randomly divided into this arm were given the same dose of ferralia with other arms,but were fed with standard infant formula (without lactoferrin supplementation)
Low level LF infant formula groupLow level LF infant formulaInfants with iron deficiency anemia randomly divided into this arm were given the same dose of ferralia with other arms,but were fed with infant formula supplemented with low level of lactoferrin (38mg/100g). Lactoferrin:38mg/100g
High level LF infant formula groupHigh level LF infant formulaInfants with iron deficiency anemia randomly divided into this arm were given the same dose of ferralia with other arms,but were fed with infant formula supplemented with high level of lactoferrin (76mg/100g)
Primary Outcome Measures
NameTimeMethod
Changes of Hb concentration(g/L)Change of Hb concentration from baseline at 1 month and 3 months.

Hb was measured by the hemoglobincyanide method

Secondary Outcome Measures
NameTimeMethod
Change of head circumference (millimeters)Changes of body weight from baseline at 1 month and 3 months.

Head circumference detected by measuring tape

Change of serum transferrin receptor concentration(mg/L)Changes of serum transferrin receptor concentration from baseline at 3 months.

Serum soluble transferrin receptor (sTfR, mg/L) was measured by microparticle-enhanced immunoassay (Sunbiote, Shanghai, China)

Change of body length (meters)Changes of body weight from baseline at 1 month and 3 months.

Body length is detected by infant height bed

Change of serum ferritin concentration (μg/L)Changes of serum iron concentration from baseline at 3 months.

concentrations of serum ferritin (SF,μg/L) were measured using a commercial enzyme-linked immunosorbent assay (ELISA; Sunbiote, Shanghai, China).

Change of body weight (kilograms)Changes of body weight from baseline at 1 month and 3 months.

Body weight is detected by electronic scale

Trial Locations

Locations (1)

Chengdu Women's and Children's Central Hospital

🇨🇳

Chengdu, China

© Copyright 2025. All Rights Reserved by MedPath